Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Antibiotic resistance is a rapidly increasing global emergency that calls for action from all of society. Intestinal multidrugresistant (MDR) bacteria have spread worldwide with extended-spectrum beta-lactamase (ESBL) -producing Enterobacteriaceae (ESBL-PE) as the most prevalent type. The millions of travelers annually visiting regions with poor hygiene contribute substantially to this spread. Our review explores the underlying data and discusses the consequences of the colonization. METHODS: PubMed was searched for relevant literature between January 2010 and August 2016. We focused on articles reporting (1) the rate of ESBL-PE acquisition in a group of travelers recruited before/after international travel, (2) fecal carriage of ESBL-PE as explored by culture and, for part of the studies, (3) analysis of factors predisposing to colonization. RESULTS: We reviewed a total of 16 studies focusing on travel-acquired ESBL-PE. The acquisition rates reveal that 2070% of visitors to (sub)tropical regions get colonized by ESBL-PE. The main risk factors predisposing to colonization during travel are destination, travelers diarrhea, and antibiotic use. CONCLUSIONS: While most of those colonized remain asymptomatic, acquisition of ESBL-PE may have consequences both at individual and community level. We discuss current efforts to restrict the spread.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In particular, resistant enteric bacteria and resistance genes that become established in local gut colonization reservoirs are more likely to be acquired by travelers 12 .”
From Urban informal settlements as hotspots of antimicrobial resistance and the need to curb environmental transmission. (2020) · cites this paper as [12]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ambler, R. P. (1980) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1980.0049 · Cited by 1,823
Colonization resistance of the digestive tract in conventional and antibiotic-treated mice
Van der Waaij, D., Berghuis-de Vries, J. M., & Lekkerkerk-van der Wees, J. E. C. (1971) · Journal of Hygiene · doi:10.1017/s0022172400021653 · Cited by 901
Escherichia coli ST131, an Intriguing Clonal Group
Nicolas-Chanoine, M.-H., Bertrand, X., & Madec, J.-Y. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00125-13 · Cited by 895
Woerther, P.-L., Burdet, C., Chachaty, E., & Andremont, A. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-13 · Cited by 686
Self-citationRodríguez-Baño, J., Navarro, M. D., Romero, L., Martínez-Martínez, L., Muniain, M. A., Perea, E. J., Pérez-Cano, R., & Pascual, A. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.3.1089-1094.2004 · Cited by 456
Karanika, S., Karantanos, T., Arvanitis, M., Grigoras, C., & Mylonakis, E. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw283 · Cited by 453
Schwaber, M. J., Navon-Venezia, S., Kaye, K. S., Ben-Ami, R., Schwartz, D., & Carmeli, Y. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1257-1262.2006 · Cited by 416
Evolution of plasmid-coded resistance to broad-spectrum cephalosporins
Kliebe, C., Nies, B. A., Meyer, J. F., Tolxdorff-Neutzling, R. M., & Wiedemann, B. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.2.302 · Cited by 415
Tängdén, T., Cars, O., Melhus, A., & Löwdin, E. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00220-10 · Cited by 372
Kantele, A., Laaveri, T., Mero, S., Vilkman, K., Pakkanen, S. H., Ollgren, J., Antikainen, J., & Kirveskari, J. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu957 · Cited by 316
Self-citationRuppé, E., Armand-Lefèvre, L., Estellat, C., Consigny, P.-H., El Mniai, A., Boussadia, Y., Goujon, C., Ralaimazava, P., Campa, P., Girard, P.-M., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ333 · Cited by 278
Self-citationLaupland, K. B., Church, D. L., Vidakovich, J., Mucenski, M., & Pitout, J. D. D. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.09.034 · Cited by 238
Hilty, M., Betsch, B. Y., Bögli-Stuber, K., Heiniger, N., Stadler, M., Küffer, M., Kronenberg, A., Rohrer, C., Aebi, S., Endimiani, A., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis581 · Cited by 226
Søraas, A., Sundsfjord, A., Sandven, I., Brunborg, C., & Jenum, P. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069581 · Cited by 223
Carbapenems: a potent class of antibiotics
Nicolau, D. P. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.1.23 · Cited by 213
Rodriguez-Bano, J., Lopez-Cerero, L., Navarro, M. D., de Alba, P. D., & Pascual, A. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn293 · Cited by 212
Lübbert, C., Straube, L., Stein, C., Makarewicz, O., Schubert, S., Mössner, J., Pletz, M. W., & Rodloff, A. C. (2015) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2014.12.001 · Cited by 204
Talukdar, P. K., Rahman, M., Rahman, M., Nabi, A., Islam, Z., Hoque, M. M., Endtz, H. P., & Islam, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061090 · Cited by 189
Reddy, P., Malczynski, M., Obias, A., Reiner, S., Jin, N., Huang, J., Noskin, G. A., & Zembower, T. (2007) · Clinical Infectious Diseases · doi:10.1086/521260 · Cited by 189
Valverde, A., Grill, F., Coque, T. M., Pintado, V., Baquero, F., Cantón, R., & Cobo, J. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01008-08 · Cited by 187
Kennedy, K., & Collignon, P. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-1031-y · Cited by 178
Östholm-Balkhed, Å., Tärnberg, M., Nilsson, M., Nilsson, L. E., Hanberger, H., Hällgren, A., & on behalf of the Travel Study Group of Southeast Sweden (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt167 · Cited by 177
Zurfluh, K., Nüesch-Inderbinen, M., Morach, M., Zihler Berner, A., Hächler, H., & Stephan, R. (2015) · Applied and Environmental Microbiology · doi:10.1128/aem.00258-15 · Cited by 171
Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam
Reuland, E. A., al Naiemi, N., Kaiser, A. M., Heck, M., Kluytmans, J. A. J. W., Savelkoul, P. H. M., Elders, P. J. M., & Vandenbroucke-Grauls, C. M. J. E. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv441 · Cited by 170
Replicon typing of plasmids in Escherichia coli producing extended-spectrum β-lactamases
Marcadé, G., Deschamps, C., Boyd, A. C., Gautier, V., Picard, B., Branger, C., Denamur, É., & Arlet, G. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn428 · Cited by 155
Kuenzli, E., Jaeger, V. K., Frei, R., Neumayr, A. L. C., DeCrom, S., Haller, S., Blum, J. A., Widmer, A. F., Furrer, H., Battegay, M., et al. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-528 · Cited by 142
Extended-Spectrum β-Lactamase–producingEnterobacteriaceaeamong Travelers from the Netherlands
Paltansing, S., Vlot, J. A., Kraakman, M. E. M., Mesman, R. L. S., Bruijning, M. L., Bernards, A. T., Visser, L. G., & Veldkamp, K. E. (2013) · Emerging infectious diseases · doi:10.3201/eid.1908.130257 · Cited by 138
Extended-Spectrum β-Lactamase–producingEnterobacteriaceaeamong Travelers from the Netherlands
Paltansing, S., Vlot, J. A., Kraakman, M. E. M., Mesman, R. L. S., Bruijning, M. L., Bernards, A. T., Visser, L. G., & Veldkamp, K. E. (2013) · Emerging infectious diseases · doi:10.3201/eid1908.130257 · Cited by 133
Osthoff, M. F., McGuinness, S. L., Wagen, A. Z., & Eisen, D. P. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.03.006 · Cited by 129
Woerther, P.-L., Angebault, C., Jacquier, H., Hugede, H.-C., Janssens, A.-C., Sayadi, S., El Mniai, A., Armand-Lefevre, L., Ruppe, E., Barbier, F., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir522 · Cited by 123
Self-citationReinheimer, C., Kempf, V. A. J., Göttig, S., Hogardt, M., Wichelhaus, T. A., O’Rourke, F., & Brandt, C. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.2.30110 · Cited by 116
Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers’ diarrhoea
Tham, J., Odenholt, I., Walder, M., Brolund, A., Ahl, J., & Melander, E. (2010) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365540903493715 · Cited by 109
Colonization of Returning Travelers With CTX‐M‐ProducingEscherichia coli
Peirano, G., Laupland, K. B., Gregson, D. B., & Pitout, J. D. D. (2011) · Journal of Travel Medicine · doi:10.1111/j.1708-8305.2011.00548.x · Cited by 103
Looking for Evidence that Personal Hygiene Precautions Prevent Traveler's Diarrhea
Shlim, D. R. (2005) · Clinical Infectious Diseases · doi:10.1086/432947 · Cited by 102
Miranda, I. B., Ignatius, R., Pfüller, R., Friedrich-Jänicke, B., Steiner, F., Paland, M., Dieckmann, S., Schaufler, K., Wieler, L. H., Guenther, S., et al. (2016) · Journal of Travel Medicine · doi:10.1093/jtm/tav024 · Cited by 80
Weisenberg, S. A., Mediavilla, J. R., Chen, L., Alexander, E. L., Rhee, K. Y., Kreiswirth, B. N., & Jenkins, S. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045141 · Cited by 78
Frequent acquisition of low-virulence strains of ESBL-producingEscherichia coliin travellers
Vading, M., Kabir, M. H., Kalin, M., Iversen, A., Wiklund, S., Nauclér, P., & Giske, C. G. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw335 · Cited by 72
Molecular epidemiology of TEM-3 (CTX-1) beta-lactamase
Petit-Paitel, A., Gerbaud, G., Sirot, D., Courvalin, P. M., & Sirot, J. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.2.219 · Cited by 66
Angelin, M., Forsell, J., Granlund, M., Evengård, B., Palmgren, H., & Johansson, A. F. (2015) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2015.04.007 · Cited by 64
Epelboin, L., Robert, J., Tsyrina-Kouyoumdjian, E., Laouira, S., Meyssonnier, V., Caumes, É., & The MDR-GNB Travel Working Group (2015) · Journal of Travel Medicine · doi:10.1111/jtm.12211 · Cited by 64
Kantele, A., Mero, S., Kirveskari, J., & Lääveri, T. (2015) · Emerging infectious diseases · doi:10.3201/eid2201.151272 · Cited by 64
Self-citationAdesoji, A. T., & Ogunjobi, A. A. (2016) · BioMed Research International · doi:10.1155/2016/7149295 · Cited by 64
Freeman, J. T., McBride, S., Heffernan, H., Bathgate, T., Pope, C., & Ellis-Pegler, R. B. (2008) · Clinical Infectious Diseases · doi:10.1086/590941 · Cited by 57
Risk Behavior for Travelers' Diarrhea Among Finnish Travelers
Mattila, L., Siitonen, A., Kyrönseppä, H., Simula, I., & Peltola, H. (1995) · Journal of Travel Medicine · doi:10.1111/j.1708-8305.1995.tb00631.x · Cited by 57
Rogers, B. A., Kennedy, K., Sidjabat, H. E., Jones, M., Collignon, P., & Paterson, D. L. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1584-z · Cited by 53
Lau, C. L., Streeton, C. L., David, M., Sly, P. D., & Mills, D. J. (2016) · Journal of Travel Medicine · doi:10.1093/jtm/tav023 · Cited by 52
Lausch, K. R., Fuursted, K., Larsen, C. S., & Storgaard, M. (2013) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2013.06.004 · Cited by 51
Kaspar, T., Schweiger, A., Droz, S., & Marschall, J. (2015) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-015-0071-6 · Cited by 44
Lääveri, T., Sterne, J., Rombo, L., & Kantele, A. (2016) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2016.06.006 · Cited by 43
Self-citationWoerther, P., Angebault, C., Jacquier, H., Clermont, O., Mniai, A. E., Moreau, B., Djossou, F., Peroz, G., Catzeflis, F. M., Denamur, É., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00848-13 · Cited by 37
Self-citationNemeth, J., Ledergerber, B., Preiswerk, B., Nobile, A., Karrer, S., Ruef, C., & Kuster, S. P. (2012) · Journal of Hospital Infection · doi:10.1016/j.jhin.2012.08.017 · Cited by 34
Vlieghe, E., Huang, T.-D., Phe, T., Bogaerts, P., Berhin, C., Smet, B. D., Peetermans, W. E., Jacobs, J. A., & Glupczynski, Y. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2350-9 · Cited by 33
Zhang, H., Zhou, Y., Guo, S., & Chang, W. (2015) · Environmental Science and Pollution Research · doi:10.1007/s11356-015-4387-9 · Cited by 29
Birgand, G., Armand-Lefèvre, L., Lepainteur, M., Lolom, I., Neulier, C., Reibel, F., Yazdanpanah, Y., Andremont, A., & Lucet, J. C. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12604 · Cited by 27
Self-citationAlagesan, M., Gopalakrishnan, R., Panchatcharam, S. N., Sureshkumar, D., Ananth, T. M., & Ramasubramanian, V. (2015) · GERMS · doi:10.11599/germs.2015.1073 · Cited by 24
Kantele, A. (2015) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2015.05.005 · Cited by 22
Self-citation
Research works printed but not linked: 1
- 1. O'Neill J. Tackling drug-resistant infections globally: Final report and recommendantions. http://amr-review.org/sites/default/files/ 160518_Final%20paper_with%20cover.pdf (15 August 2016, date last accessed).
Cited by
Global geographic trends in antimicrobial resistance: the role of international travel
Frost, I., Van Boeckel, T. P., Pires, J., Craig, J., & Laxminarayan, R. (2019) · Journal of Travel Medicine · doi:10.1093/jtm/taz036 · Cited by 338
Nadimpalli, M. L., Marks, S. J., Montealegre, M. C., Gilman, R. H., Pajuelo, M. J., Saito, M., Tsukayama, P., Njenga, S. M., Kiiru, J., Swarthout, J., et al. (2020) · Nature microbiology · doi:10.1038/s41564-020-0722-0 · Cited by 223
Day, M. J., Hopkins, K. L., Wareham, D. W., Toleman, M. A., Elviss, N., Randall, L., Teale, C., Cleary, P., Wiuff, C., Doumith, M., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30273-7 · Cited by 200
Lai, C. K. C., Ng, R. W. Y., Leung, S. S. Y., Hui, M., & Ip, M. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114078 · Cited by 106
Goyal, D., Dean, N. C., Neill, S., Jones, P. B., & Dascomb, K. K. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy357 · Cited by 93
Metadata
- Authors
- Woerther, P.-L., Andremont, A., & Kantele, A.
- Affiliations
- Institut Gustave Roussy (FR)
- Inserm (FR)
- University of Helsinki (FI)
- Corresponding author
- Kantele, Anu
- Venue
- Journal of Travel Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-04
- Volume
- 24
- Issue
- suppl_1
- Pages
- S29-S34
- ISSN
- 1195-1982 (ISSN-L)
- 1708-8305
- PMC
- PMC5441303
- OpenAlex
- W2609675593
- Cited by
- 142
- References
- 56
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 12 · 2023: 14 · 2022: 8 · 2021: 24 · 2020: 23 · 2019: 25 · 2018: 15 · 2017: 4
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Journal of Travel Medicine (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Scandinavian Society for Antimicrobial Chemotherapy Foundation
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Travel-related health issues
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- extended-spectrum beta-lactamase, ESBL-producing Enterobacteriaceae, travel-associated infection, fecal carriage, multidrug-resistant bacteria, international travel, traveler's diarrhea, antibiotic use, risk factors, antibiotic resistance spread
- MeSH terms
- Anti-Bacterial Agents, beta-Lactamases, Diarrhea, Enterobacteriaceae, Enterobacteriaceae Infections, Humans, Travel, Drug Resistance, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.